glp 1 boehringer glp-1-dual-agonist-survodutide-weightloss-obesity-overweight-improvement 🚨 Survodutide, a weekly subcutaneous

These typically resolve within several weeks as the body adjusts to treatment

This etiology should be considered in a hypoglycemia patient with a negative 72 hour fast, positive mixed meal test concerning for endogenous hyperinsulinism without a history of GI surgery, and negative imaging for insulinoma

A moderate walk provides benefits even when a high intensity interval session feels impossible

Before We Label It Resistant We must first rule out: 1 Poor blood pressure measurement technique 2 Medication non-adherence 3 White-coat hypertension (confirm with home or ambulatory monitoring) 4 Inadequate drug dosing 5 Clinical inertia Many cases are actually pseudo-resistant hypertension